What is the treatment for sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Sinusitis

For acute bacterial sinusitis, start with amoxicillin or amoxicillin-clavulanate as first-line therapy for 10-14 days, reserving high-dose amoxicillin-clavulanate for patients with severe disease, recent antibiotic exposure, or those in regions with high bacterial resistance. 1, 2

Acute Bacterial Sinusitis

First-Line Antibiotic Selection

  • Amoxicillin is the preferred initial agent for uncomplicated acute bacterial sinusitis in both adults and children, given its effectiveness, low cost, and favorable tolerability profile 2
  • Amoxicillin-clavulanate (500-875 mg twice daily for adults; 22.5-45 mg/kg twice daily for children based on amoxicillin component) is recommended as an alternative first-line option, particularly when beta-lactamase-producing organisms are suspected 1
  • Recent high-quality evidence shows that high-dose amoxicillin-clavulanate does not provide superior clinical outcomes compared to standard-dose formulations in adults with clinically diagnosed acute sinusitis, though it may increase the risk of severe diarrhea 3, 4

Treatment Duration and Response Assessment

  • Standard treatment duration is 10-14 days for most antibiotics, continuing until the patient is symptom-free for 7 days 1, 2
  • Evaluate clinical response after 3-5 days of initial therapy 1, 2
  • If symptoms are improving, complete the full 10-14 day course 2
  • If no improvement occurs after 3-5 days, switch to a different antibiotic class 2

Severity-Based Treatment Algorithm

For mild acute bacterial sinusitis:

  • Start with amoxicillin or standard-dose amoxicillin-clavulanate 1
  • Reassess at 3-5 days 1

For moderate to severe sinusitis or recent antibiotic use:

  • Begin with high-dose amoxicillin-clavulanate or a respiratory fluoroquinolone 1

For penicillin-allergic patients:

  • Second-generation cephalosporins (cefuroxime axetil) or third-generation cephalosporins (cefpodoxime proxetil, cefdinir) are appropriate alternatives 1, 5
  • Macrolides (azithromycin) may be used in non-severe cases and areas with low resistance 5, 6
  • Respiratory fluoroquinolones (levofloxacin 500 mg daily for 10-14 days OR 750 mg daily for 5 days) are reserved for treatment failures or complicated cases 1, 7

Second-Line Options for Treatment Failure

  • If symptoms persist after initial therapy, switch to high-dose amoxicillin-clavulanate if not already used 2
  • Alternative second-line agents include cefuroxime, cefpodoxime, cefprozil, or cefdinir 2
  • For protracted cases (21-28 days without improvement), consider broader-spectrum antibiotics with anaerobic coverage (clindamycin or metronidazole in combination) 1, 2

Chronic Sinusitis

Initial Treatment Approach

  • Amoxicillin-clavulanate is first-line therapy for chronic ethmoid sinusitis due to effectiveness against common pathogens including resistant bacteria 5
  • Treatment duration is typically 10-14 days initially, with continuation for another 10-14 days if partial response occurs 5
  • For penicillin-allergic patients, use cephalosporins (cefuroxime, cefpodoxime, cefprozil, cefdinir) for 10-14 days 5

Essential Adjunctive Therapies

Intranasal corticosteroids:

  • Recommended as adjunct to antibiotics for both acute and chronic sinusitis, particularly with marked mucosal edema 1, 5
  • Continue daily throughout treatment course 5

Saline irrigation:

  • Perform 2-3 times daily to improve mucociliary clearance and reduce nasal congestion 5
  • Continue throughout treatment and beyond 5

Oral decongestants:

  • May be used short-term (maximum 5 days) to decrease nasal resistance and improve ostial patency 5, 2
  • Critical pitfall: Prolonged use beyond 5 days leads to rhinitis medicamentosa (rebound congestion) 5

Special Considerations and Red Flags

High-Risk Anatomic Locations

  • Frontal, ethmoidal, or sphenoidal sinusitis requires more aggressive treatment due to higher complication risk 1
  • Consider earlier specialist referral and imaging for these locations 1

Complications Requiring Immediate Hospitalization

  • Orbital involvement (periorbital edema, vision changes, ophthalmoplegia) 1
  • Neurological symptoms (severe headache, altered mental status, meningeal signs) 1
  • These require immediate hospitalization and parenteral antibiotics 1

Underlying Conditions to Evaluate

  • Assess for allergic rhinitis, immunodeficiency, or anatomical abnormalities in patients with chronic or recurrent sinusitis 1, 5
  • Consider referral to allergist-immunologist or otolaryngologist if medical therapy fails 5
  • Surgical intervention may be necessary for medically resistant cases 5

Common Pitfalls to Avoid

  • Overdiagnosis: Only prescribe antibiotics when symptoms last ≥10-14 days OR severe symptoms (fever, purulent discharge, facial pain) are present for 3-4 consecutive days 2
  • Inadequate duration: Patients must complete the full 10-14 day course even if symptoms improve earlier to prevent relapse 2
  • Wrong spectrum: Inadequate antibiotic spectrum for chronic sinusitis leads to treatment failure 5
  • Ignoring underlying causes: Failure to address allergic rhinitis or other risk factors perpetuates the problem 5
  • Decongestant overuse: Limit topical/oral decongestants to 5 days maximum 5
  • Delayed referral: Refer to specialist if symptoms persist beyond 21-28 days of appropriate antibiotic therapy with CT imaging 1

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment for Chronic Ethmoid Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.